Data / Form D filings / Azelon Pharmaceuticals, Inc.
Azelon Pharmaceuticals, Inc.: Form D filings
Azelon Pharmaceuticals, Inc., a pharmaceuticals company in West Conshohocken, PA, filed 7 Form D notices with the SEC between 2009 and 2012. The latest, on March 16, 2012, reports $2.4 million sold of a $2.4 million offering to 6 investors.
Find out what Azelon Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- FOUR TOWER BRIDGE, 200 BARR HARBOR DRIVE, SUITE 400, West Conshohocken, PA, 19428
- Phone
- (610) 260-6045
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1286667
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 16, 2012 | New notice | $2,422,000 | $2,422,000 | $0 | 6 | Mar 7, 2012 | sec.gov |
| Aug 17, 2011 | New notice | $2,793,488 | $2,793,488 | $0 | 5 | Aug 3, 2011 | sec.gov |
| May 23, 2011 | New notice | $250,000 | $41,666 | $208,334 | 1 | May 11, 2011 | sec.gov |
| May 20, 2010 | New notice | $13,627,304 | $922,243 | $12,705,061 | 6 | May 7, 2010 | sec.gov |
| Jun 9, 2009 | Amendment | $12,500,000 | $9,125,000 | $3,375,000 | 16 | May 29, 2009 | sec.gov |
| May 8, 2009 | Amendment | $1,500,000 | $1,500,000 | $0 | 6 | Mar 3, 2009 | sec.gov |
| Apr 10, 2009 | Amendment | $1,000,000 | $1,000,000 | $0 | 6 | Mar 3, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joan Lau | Executive Officer, Director | |
| Joseph Zakrzewski | Director | |
| Lily Lam | Director | |
| Donald Hayden | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
Every Form D from the week of Mar 12, 2012 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Azelon Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.